Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProstaCare Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia

NCT02962674 is registered in ClinicalTrials.gov with ProstaCare Singapore Pte. Ltd. as lead sponsor.

NCT NCT02962674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02962674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProstaCare Water Electrolysis System for the Treatment of Benign Prostatic Hyperplasia
Lead sponsor
ProstaCare Singapore Pte. Ltd.
Phase
Not applicable
Overall status
Terminated
Start date
September 19, 2016
Completion date
November 20, 2020
Enrollment
49 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia